AR058923A1 - Soluciones esterilizadas para dialisis peritoneal que contienen heparina - Google Patents

Soluciones esterilizadas para dialisis peritoneal que contienen heparina

Info

Publication number
AR058923A1
AR058923A1 ARP070100045A ARP070100045A AR058923A1 AR 058923 A1 AR058923 A1 AR 058923A1 AR P070100045 A ARP070100045 A AR P070100045A AR P070100045 A ARP070100045 A AR P070100045A AR 058923 A1 AR058923 A1 AR 058923A1
Authority
AR
Argentina
Prior art keywords
solutions
peritoneal dialysis
combinations
group
solution
Prior art date
Application number
ARP070100045A
Other languages
English (en)
Spanish (es)
Original Assignee
Baxter C Edward Jr
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter C Edward Jr, Baxter Healthcare Sa filed Critical Baxter C Edward Jr
Publication of AR058923A1 publication Critical patent/AR058923A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP070100045A 2006-01-05 2007-01-04 Soluciones esterilizadas para dialisis peritoneal que contienen heparina AR058923A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/326,236 US20070155672A1 (en) 2006-01-05 2006-01-05 Sterilized peritoneal dialysis solutions containing heparin

Publications (1)

Publication Number Publication Date
AR058923A1 true AR058923A1 (es) 2008-03-05

Family

ID=38225289

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070100045A AR058923A1 (es) 2006-01-05 2007-01-04 Soluciones esterilizadas para dialisis peritoneal que contienen heparina

Country Status (8)

Country Link
US (1) US20070155672A1 (cg-RX-API-DMAC7.html)
EP (1) EP1988908A2 (cg-RX-API-DMAC7.html)
JP (1) JP2009522054A (cg-RX-API-DMAC7.html)
CN (1) CN101394855A (cg-RX-API-DMAC7.html)
AR (1) AR058923A1 (cg-RX-API-DMAC7.html)
MX (1) MX2008008701A (cg-RX-API-DMAC7.html)
TW (1) TW200800237A (cg-RX-API-DMAC7.html)
WO (1) WO2007079338A2 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090286740A1 (en) * 2008-05-15 2009-11-19 Fibrex Medical Research & Development Gmbh Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
EA034858B1 (ru) * 2015-01-30 2020-03-30 Фрезениус Каби Дойчланд Гмбх Применение модифицированных полимеров глюкозы для снижения метастазирования опухолей
EP3766529A4 (en) * 2018-03-14 2022-03-23 Beacon Medcare (HK) Limited Composition for purification of biofluids
CN114504953B (zh) * 2022-03-14 2023-06-16 上海翊科聚合物科技有限公司 一种中空纤维血液透析膜的制备方法
CN118436679B (zh) * 2024-05-07 2024-09-17 南京汉科明德医疗科技有限公司 一种高稳定性的艾考糊精透析液及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3030272A (en) * 1960-05-26 1962-04-17 Abbott Lab Stable heaparin solution
DK0555087T3 (da) * 1992-02-04 1999-05-03 Baxter Int Peritoneale dialyseopløsninger indeholdende mindst ét dipeptid
SE9900043D0 (sv) * 1999-01-11 1999-01-11 Astra Ab New use
IT1274351B (it) * 1994-10-06 1997-07-17 Alfa Wassermann Spa Uso di alcuni glicosaminoglicani nella dialisi peritoneale.
CA2155910C (en) * 1995-08-11 1999-12-14 George Wu Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
JP4882054B2 (ja) * 2000-09-13 2012-02-22 独立行政法人科学技術振興機構 腹膜透析液およびその調製法
US20060046975A1 (en) * 2002-12-10 2006-03-02 Ola Carlsson Method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
US7141544B2 (en) * 2003-10-10 2006-11-28 Baxter International, Inc. Stabilization of pharmaceutical protein formulations with small peptides

Also Published As

Publication number Publication date
WO2007079338A2 (en) 2007-07-12
MX2008008701A (es) 2009-03-04
CN101394855A (zh) 2009-03-25
WO2007079338A3 (en) 2008-11-27
US20070155672A1 (en) 2007-07-05
JP2009522054A (ja) 2009-06-11
EP1988908A2 (en) 2008-11-12
TW200800237A (en) 2008-01-01

Similar Documents

Publication Publication Date Title
Vivcharenko et al. Elastic and biodegradable chitosan/agarose film revealing slightly acidic pH for potential applications in regenerative medicine as artificial skin graft
Liang et al. An in situ formed biodegradable hydrogel for reconstruction of the corneal endothelium
CN105339017B (zh) 种植体的表面处理方法
EP3170391A1 (en) Lamellar cornea preserving solution
JP2013533093A5 (cg-RX-API-DMAC7.html)
JP2015529268A5 (cg-RX-API-DMAC7.html)
ES2364122T3 (es) Composiciones oftálmicas que comprenden un fructano modificado con carboxilo o una sal del mismo.
ATE452659T1 (de) Verfahren zur sterilisation verpackter kontaktlinsen mit verpackungslösung
AR062212A1 (es) Composicion y metodo en relacion con la prevencion y la solucion del dano del gel surfactante
CN104958791A (zh) 一种青光眼外科手术用复合生物基质及其制备方法
Jiang et al. A polymer–extracellular matrix composite with improved thromboresistance and recellularization properties
JP2021157197A (ja) シリコーンハイドロゲルコンタクトレンズ用眼科組成物
JP2007105265A (ja) 生物由来スキャフォールドの作製方法
JP2010540619A5 (cg-RX-API-DMAC7.html)
CN108578772B (zh) 一种用于提升生物相容性的血液接触材料制备方法及血液接触材料
CN103480033A (zh) 一种医用生物多糖止血愈合海绵及其制备方法
MX2010006650A (es) Materiales y metodos para el tratamiento de proliferacion vascular ocular patologica.
CN103638562A (zh) 软骨组织工程支架材料及其制备方法
JP2016534118A (ja) 動物組織材料の消毒・滅菌方法及び動物組織浸漬溶液
CN102470115B (zh) 硅酮水凝胶隐形眼镜用眼科组合物
Jiang et al. Facilitation of Cell Cycle and Cellular Migration of Rat Schwann Cells by O‐Carboxymethyl Chitosan to Support Peripheral Nerve Regeneration
CN103224654B (zh) 一种硫化银量子点-壳聚糖纳米复合物的制备方法
CN115942964A (zh) 用于将溶液中的有机化合物并入水凝胶中的方法
Grolik et al. Corneal epithelial scaffolds based on chitosan membranes containing collagen and keratin
AR077458A1 (es) Composiciones de copolimero en bloque de oxido de etileno oxido de butileno

Legal Events

Date Code Title Description
FA Abandonment or withdrawal